By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
12-Item Multiple Sclerosis Walking Scale (MSWS-12)
Summary
What it measures:
Impact of MS on the individual’s walking ability (self-report)
Target Population:
Multiple sclerosis (MS)
MS EDGE Recommendations
Highly recommended in acute care, inpatient rehabilitation, home health, skilled nursing, and outpatient care
Highly recommended for EDSS levels 0.0-3.5, 4.0-5.5, and 6.0-7.5.
Instructions state that if individual cannot walk at all, the requested box should be checked and no items should be completed.
Recommended as a good indicator of actual walking behavior in people with EDSS 3.5‐7.5 outside the clinical/laboratory spotlight because of high correlation with daily step count as recorded by a step activity monitor during all waking hours for up to 7 days (Cavanaugh et al, 2011)
For more information on this and other measures, refer to original document: http://www.neuropt.org/docs/ms-edge-documents/final-ms-edge-document.pdf?sfvrsn=4
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: January 21, 2015
Contact: practice@apta.org
Content Type: Test & Measure
For MS EDGE: Diane D. Allen, PT, PhD
You Might Also Like...
CPG
American College of Chest Physicians and Canadian Thoracic Society Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
This guideline was created by the American College of Chest Physicians and Canadian Thoracic Society to help clinicians and patients gauge the appropriate
CPG
Multiple Sclerosis in Adults: Management [NICE NG220]
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple